TRETINOIN

TRETINOIN was reported 8222 times

These side effects are most commonly reported by patients taking TRETINOIN:

# Side effect Count
0 OFF LABEL USE 989
1 DRUG INEFFECTIVE 858
2 PAIN 605
3 PRODUCT USE IN UNAPPROVED INDICATION 512
4 VOMITING 510
5 NAUSEA 454
6 RASH 448
7 HEADACHE 436
8 DIARRHOEA 418
9 PARAESTHESIA 404
10 ABDOMINAL PAIN UPPER 388
11 FATIGUE 379
12 HYPOAESTHESIA 368
13 DEPRESSION 354
14 DRUG INTOLERANCE 346
15 GASTROOESOPHAGEAL REFLUX DISEASE 346
16 MATERNAL EXPOSURE DURING PREGNANCY 346
17 ARTHRALGIA 344
18 TASTE DISORDER 334
19 CONDITION AGGRAVATED 332
20 DIZZINESS 332
21 MEMORY IMPAIRMENT 323
22 MIGRAINE 314
23 EPILEPSY 309
24 PRURITUS 309
25 BLEPHAROSPASM 308
26 PNEUMONIA 290
27 ASTHENIA 285
28 ALOPECIA 280
29 PRODUCT USE ISSUE 273
30 ANXIETY 269
31 PRODUCT QUALITY ISSUE 267
32 WEIGHT INCREASED 266
33 ABDOMINAL DISCOMFORT 258
34 DRY SKIN 256
35 DYSPNOEA 249
36 DRUG HYPERSENSITIVITY 247
37 PYREXIA 242
38 URTICARIA 241
39 TREATMENT FAILURE 240
40 ERYTHEMA 235
41 DIFFERENTIATION SYNDROME 233
42 PAIN IN EXTREMITY 229
43 GENERAL PHYSICAL HEALTH DETERIORATION 228
44 HYPERTENSION 224
45 RHEUMATOID ARTHRITIS 223
46 MUSCLE SPASMS 221
47 PERIPHERAL SWELLING 219
48 BLISTER 217
49 NASOPHARYNGITIS 214
50 NECK PAIN 211
51 WOUND 210
52 INJURY 209
53 DRY MOUTH 208
54 PERICARDITIS 205
55 SYNOVITIS 205
56 SWELLING 204
57 OSTEOARTHRITIS 202
58 PSORIATIC ARTHROPATHY 202
59 BLOOD CHOLESTEROL INCREASED 198
60 JOINT SWELLING 197
61 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 196
62 SLEEP DISORDER 195
63 INFLAMMATION 194
64 ARTHROPATHY 193
65 CONTRAINDICATED PRODUCT ADMINISTERED 193
66 STOMATITIS 193
67 IRRITABLE BOWEL SYNDROME 191
68 SKIN EXFOLIATION 189
69 MUSCULAR WEAKNESS 188
70 CONFUSIONAL STATE 187
71 INTENTIONAL PRODUCT USE ISSUE 186
72 THERAPEUTIC PRODUCT EFFECT DECREASED 186
73 NIGHT SWEATS 185
74 PRODUCT DOSE OMISSION ISSUE 180
75 ACNE 176
76 FOLLICULITIS 176
77 HEPATIC ENZYME INCREASED 176
78 BURSITIS 175
79 INSOMNIA 175
80 TYPE 2 DIABETES MELLITUS 174
81 GLOSSODYNIA 173
82 BREAST CANCER STAGE III 171
83 SYSTEMIC LUPUS ERYTHEMATOSUS 171
84 BACK INJURY 169
85 INFUSION RELATED REACTION 168
86 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 166
87 FIBROMYALGIA 165
88 PERIPHERAL VENOUS DISEASE 165
89 PEMPHIGUS 164
90 RHEUMATIC FEVER 164
91 MUSCULOSKELETAL PAIN 162
92 HYPERSENSITIVITY 161
93 C-REACTIVE PROTEIN INCREASED 160
94 LIP DRY 160
95 IMPAIRED HEALING 155
96 LIVE BIRTH 155
97 ONYCHOMADESIS 155
98 WHEEZING 155
99 DUODENAL ULCER PERFORATION 154
100 ABDOMINAL PAIN 153
101 GAIT INABILITY 152
102 MALAISE 152
103 LUNG DISORDER 150
104 HAND DEFORMITY 147
105 EXPOSURE DURING PREGNANCY 146
106 WEIGHT DECREASED 145
107 DECREASED APPETITE 144
108 FACET JOINT SYNDROME 143
109 WOUND INFECTION 143
110 MUSCLE INJURY 142
111 INFECTION 138
112 JOINT RANGE OF MOTION DECREASED 138
113 MOBILITY DECREASED 136
114 FEBRILE NEUTROPENIA 135
115 HYPERCHOLESTEROLAEMIA 131
116 THROMBOCYTOPENIA 131
117 BACK PAIN 129
118 HELICOBACTER INFECTION 129
119 NEUTROPENIA 129
120 FALL 128
121 OBESITY 127
122 ANAEMIA 126
123 NAIL DISORDER 126
124 LIVER FUNCTION TEST INCREASED 123
125 LIVER INJURY 123
126 LOWER RESPIRATORY TRACT INFECTION 123
127 CONTUSION 122
128 PSORIASIS 119
129 VISUAL IMPAIRMENT 115
130 SINUSITIS 114
131 ASTHMA 113
132 DEATH 111
133 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 111
134 INFUSION SITE REACTION 111
135 CHEST PAIN 108
136 GAIT DISTURBANCE 105
137 INJECTION SITE PAIN 103
138 MYALGIA 103
139 APPLICATION SITE ERYTHEMA 102
140 CONSTIPATION 101
141 OEDEMA 98
142 MUSCULOSKELETAL STIFFNESS 97
143 ABDOMINAL DISTENSION 96
144 DRUG INTERACTION 96
145 DISCOMFORT 95
146 GASTROINTESTINAL DISORDER 95
147 EMOTIONAL DISTRESS 94
148 OVERLAP SYNDROME 92
149 SEPSIS 90
150 ACUTE KIDNEY INJURY 89
151 COUGH 89
152 ACUTE MYELOID LEUKAEMIA 86
153 FEELING ABNORMAL 86
154 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 85
155 DYSPEPSIA 84
156 HAEMORRHAGE 83
157 OEDEMA PERIPHERAL 80
158 APPLICATION SITE PAIN 79
159 SUICIDAL IDEATION 79
160 ACUTE PROMYELOCYTIC LEUKAEMIA DIFFERENTIATION SYNDROME 78
161 CHRONIC KIDNEY DISEASE 77
162 SOMNOLENCE 77
163 SURGERY 76
164 PULMONARY EMBOLISM 75
165 RENAL FAILURE 73
166 RETINOIC ACID SYNDROME 72
167 SKIN IRRITATION 71
168 ADVERSE EVENT 69
169 ADVERSE DRUG REACTION 68
170 APPLICATION SITE EXFOLIATION 68
171 DEEP VEIN THROMBOSIS 68
172 EAR PAIN 68
173 THERAPY NON-RESPONDER 68
174 URINARY TRACT INFECTION 68
175 ABORTION SPONTANEOUS 67
176 DERMATITIS ATOPIC 67
177 DISLOCATION OF VERTEBRA 67
178 LOSS OF CONSCIOUSNESS 67
179 SKIN BURNING SENSATION 66
180 SKIN DISCOLOURATION 66
181 HYPOTENSION 65
182 MUCOSAL INFLAMMATION 65
183 OSTEOPOROSIS 65
184 PRODUCT ADMINISTRATION INTERRUPTED 65
185 AMNESIA 64
186 FEELING HOT 64
187 COVID-19 63
188 DRUG-INDUCED LIVER INJURY 63
189 ELECTROCARDIOGRAM QT PROLONGED 63
190 RED BLOOD CELL SEDIMENTATION RATE INCREASED 63
191 BURNING SENSATION 62
192 CHILLS 62
193 COLITIS ULCERATIVE 62
194 ILLNESS 62
195 MYELODYSPLASTIC SYNDROME 62
196 SKIN DISORDER 62
197 PALPITATIONS 60
198 VISION BLURRED 60
199 COELIAC DISEASE 59
200 DRY EYE 59
201 ECZEMA 59
202 GRIP STRENGTH DECREASED 58
203 BREAST CANCER STAGE II 57
204 TREMOR 57
205 BLOOD PRESSURE INCREASED 55
206 EXOSTOSIS 55
207 LUPUS VULGARIS 55
208 UPPER RESPIRATORY TRACT INFECTION 55
209 NEUROPATHY PERIPHERAL 54
210 AUTOIMMUNE DISORDER 53
211 CROHN^S DISEASE 53
212 DELIRIUM 53
213 DYSPHAGIA 53
214 INTRACRANIAL PRESSURE INCREASED 53
215 NO ADVERSE EVENT 53
216 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 53
217 HOSPITALISATION 52
218 NORMAL NEWBORN 52
219 PRESCRIBED OVERDOSE 51
220 PULMONARY FIBROSIS 51
221 RHEUMATOID FACTOR POSITIVE 51
222 STRESS 51
223 INFLAMMATORY BOWEL DISEASE 50
224 THERAPEUTIC RESPONSE UNEXPECTED 50
225 ILL-DEFINED DISORDER 49
226 SEIZURE 49
227 APPLICATION SITE IRRITATION 48
228 BRONCHITIS 48
229 RESPIRATORY FAILURE 48
230 ROAD TRAFFIC ACCIDENT 48
231 UNEVALUABLE EVENT 48
232 ANHEDONIA 47
233 PANCYTOPENIA 47
234 RESPIRATORY DISORDER 47
235 C-REACTIVE PROTEIN ABNORMAL 46
236 SWOLLEN JOINT COUNT INCREASED 46
237 OVERDOSE 45
238 RHINORRHOEA 45
239 TACHYCARDIA 45
240 DEEP VEIN THROMBOSIS POSTOPERATIVE 44
241 HYPERCALCAEMIA 44
242 HYPERHIDROSIS 44
243 LIVER DISORDER 44
244 ORAL HERPES 44
245 OROPHARYNGEAL PAIN 44
246 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 44
247 HEART RATE INCREASED 43
248 IDIOPATHIC INTRACRANIAL HYPERTENSION 43
249 PHOTOPHOBIA 43
250 INJECTION SITE REACTION 42
251 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 42
252 EYE IRRITATION 41
253 HAEMORRHAGE INTRACRANIAL 41
254 HALLUCINATION 41
255 RASH PRURITIC 41
256 SCIATICA 41
257 SYNCOPE 41
258 ACCIDENTAL EXPOSURE TO PRODUCT 40
259 EYE SWELLING 40
260 INCORRECT DOSE ADMINISTERED 40
261 LEUKAEMIA RECURRENT 40
262 LOWER LIMB FRACTURE 40
263 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 40
264 HEPATOTOXICITY 39
265 RASH ERYTHEMATOUS 39
266 RETINITIS 39
267 WHITE BLOOD CELL COUNT DECREASED 39
268 WHITE BLOOD CELL COUNT INCREASED 39
269 ACUTE PROMYELOCYTIC LEUKAEMIA 38
270 ANAPHYLACTIC REACTION 38
271 APPLICATION SITE DRYNESS 38
272 DEHYDRATION 38
273 EXPIRED PRODUCT ADMINISTERED 38
274 EYE PAIN 38
275 FUNGAL INFECTION 38
276 PLEURAL EFFUSION 38
277 SLEEP APNOEA SYNDROME 38
278 ASPARTATE AMINOTRANSFERASE INCREASED 37
279 FREQUENT BOWEL MOVEMENTS 37
280 INJECTION SITE ERYTHEMA 37
281 PRODUCT PHYSICAL CONSISTENCY ISSUE 37
282 SWELLING FACE 37
283 BONE EROSION 36
284 COLITIS 36
285 DISEASE PROGRESSION 36
286 FLUSHING 36
287 HEPATIC CIRRHOSIS 36
288 HEPATITIS 36
289 PRESCRIBED UNDERDOSE 36
290 PRODUCT LABEL CONFUSION 36
291 PRODUCT SUBSTITUTION ISSUE 36
292 THERAPEUTIC RESPONSE DECREASED 36
293 APPLICATION SITE PRURITUS 35
294 CHEST DISCOMFORT 35
295 INTENTIONAL DOSE OMISSION 35
296 INTENTIONAL PRODUCT MISUSE 35
297 PANIC ATTACK 35
298 RASH MACULAR 35
299 UNDERDOSE 35
300 ARTHRITIS 34
301 BENIGN INTRACRANIAL HYPERTENSION 34
302 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 33
303 HAEMOGLOBIN DECREASED 33
304 INTESTINAL OBSTRUCTION 33
305 JOINT STIFFNESS 33
306 LARYNGITIS 33
307 NEPHROLITHIASIS 33
308 SEPTIC SHOCK 33
309 THINKING ABNORMAL 33
310 DISABILITY 32
311 INFLUENZA 32
312 ORAL PAIN 32
313 TREATMENT NONCOMPLIANCE 32
314 VERTIGO 32
315 BONE PAIN 31
316 FLUID RETENTION 31
317 LEUKOPENIA 31
318 NEUTROPENIC SEPSIS 31
319 PRE-EXISTING CONDITION IMPROVED 31
320 RENAL IMPAIRMENT 31
321 ALANINE AMINOTRANSFERASE INCREASED 30
322 CEREBROVASCULAR ACCIDENT 30
323 EPISTAXIS 30
324 FOETAL EXPOSURE DURING PREGNANCY 30
325 HYPOCHOLESTEROLAEMIA 30
326 INTERSTITIAL LUNG DISEASE 30
327 LEUKOCYTOSIS 30
328 MYELOSUPPRESSION 30
329 PANCREATITIS 30
330 SJOGREN^S SYNDROME 30
331 SKIN WARM 30
332 TENDERNESS 30
333 APPLICATION SITE DISCOLOURATION 29
334 BLOOD CREATININE INCREASED 29
335 DISSEMINATED INTRAVASCULAR COAGULATION 29
336 MEDICATION ERROR 29
337 MYELODYSPLASTIC SYNDROME TRANSFORMATION 29
338 MYOSITIS 29
339 PLATELET COUNT DECREASED 29
340 PULMONARY OEDEMA 29
341 RASH VESICULAR 29
342 RECTAL HAEMORRHAGE 29
343 SCAR 29
344 ATRIAL FIBRILLATION 28
345 CELLULITIS 28
346 DERMATITIS 28
347 DEVICE DISLOCATION 28
348 FINGER DEFORMITY 28
349 HAEMORRHOIDS 28
350 HIP ARTHROPLASTY 28
351 HYPOKALAEMIA 28
352 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 28
353 INJECTION SITE SWELLING 28
354 KNEE ARTHROPLASTY 28
355 OCULAR HYPERAEMIA 28
356 SECOND PRIMARY MALIGNANCY 28
357 SNEEZING 28
358 X-RAY ABNORMAL 28
359 CARDIAC FAILURE CONGESTIVE 27
360 DRUG DOSE OMISSION 27
361 EYE PRURITUS 27
362 HYPOXIA 27
363 INJECTION SITE PRURITUS 27
364 NASAL CONGESTION 27
365 STAPHYLOCOCCAL INFECTION 27
366 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 27
367 TOXICITY TO VARIOUS AGENTS 27
368 CARDIAC ARREST 26
369 DYSPHORIA 26
370 EAR INFECTION 26
371 INFLUENZA LIKE ILLNESS 26
372 PRODUCT PRESCRIBING ISSUE 26
373 SUICIDE ATTEMPT 26
374 THERAPY INTERRUPTED 26
375 CHOLECYSTITIS CHRONIC 25
376 DISTURBANCE IN ATTENTION 25
377 EYE DISORDER 25
378 IMPAIRED QUALITY OF LIFE 25
379 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 25
380 ONYCHOMYCOSIS 25
381 PERICARDIAL EFFUSION 25
382 PREGNANCY 25
383 PULMONARY HAEMORRHAGE 25
384 PUSTULAR PSORIASIS 25
385 SKIN LESION 25
386 THROMBOSIS 25
387 ADVERSE REACTION 24
388 APPETITE DISORDER 24
389 APPLICATION SITE SWELLING 24
390 BALANCE DISORDER 24
391 C-REACTIVE PROTEIN 24
392 CARDIAC FAILURE 24
393 DEVICE BREAKAGE 24
394 DEVICE ISSUE 24
395 MYOCARDIAL INFARCTION 24
396 OSTEOPENIA 24
397 PAPILLOEDEMA 24
398 AGITATION 23
399 CEREBRAL HAEMORRHAGE 23
400 CHOLELITHIASIS 23
401 ECONOMIC PROBLEM 23
402 HYPERLEUKOCYTOSIS 23
403 INJECTION SITE BRUISING 23
404 JOINT DISLOCATION 23
405 LUPUS-LIKE SYNDROME 23
406 LYMPHOPENIA 23
407 MYOCARDITIS 23
408 SKIN WRINKLING 23
409 BLOOD GLUCOSE INCREASED 22
410 HAEMORRHAGIC DIATHESIS 22
411 MALIGNANT NEOPLASM PROGRESSION 22
412 NEUROTOXICITY 22
413 RENAL FAILURE ACUTE 22
414 RESPIRATORY DISTRESS 22
415 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 21
416 ACUTE RESPIRATORY FAILURE 21
417 ARTHRITIS INFECTIVE 21
418 CROHN'S DISEASE 21
419 DEVICE EXPULSION 21
420 FOOT DEFORMITY 21
421 HOT FLUSH 21
422 TINNITUS 21
423 BLOOD PRESSURE DECREASED 20
424 BONE DENSITY DECREASED 20
425 CHEILITIS 20
426 DEPRESSED MOOD 20
427 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 20
428 DRUG EXPOSURE DURING PREGNANCY 20
429 FOOT FRACTURE 20
430 GALLBLADDER DISORDER 20
431 HAEMATOCHEZIA 20
432 HAEMATOPOIETIC NEOPLASM 20
433 IRRITABILITY 20
434 MULTI-ORGAN FAILURE 20
435 MULTIPLE ORGAN DYSFUNCTION SYNDROME 20
436 OXYGEN SATURATION DECREASED 20
437 POOR QUALITY PRODUCT ADMINISTERED 20
438 PRODUCT STORAGE ERROR 20
439 THERAPY CESSATION 20
440 ULCER HAEMORRHAGE 20
441 VAGINAL HAEMORRHAGE 20
442 ACUTE RESPIRATORY DISTRESS SYNDROME 19
443 COMPLICATION OF DEVICE INSERTION 19
444 COMPLICATION OF DEVICE REMOVAL 19
445 DIABETES MELLITUS 19
446 DISORIENTATION 19
447 FACIAL PAIN 19
448 JOINT INJURY 19
449 BLOOD BILIRUBIN INCREASED 18
450 BONE MARROW NECROSIS 18
451 CONJUNCTIVITIS 18
452 DISEASE RECURRENCE 18
453 DYSPHONIA 18
454 HYPOTHYROIDISM 18
455 MATERNAL EXPOSURE TIMING UNSPECIFIED 18
456 PAIN OF SKIN 18
457 POLLAKIURIA 18
458 PRODUCT DOSE OMISSION IN ERROR 18
459 SPEECH DISORDER 18
460 WALKING AID USER 18
461 ACUTE MYOCARDIAL INFARCTION 17
462 APPLICATION SITE RASH 17
463 BLOOD ALKALINE PHOSPHATASE INCREASED 17
464 BLOOD TRIGLYCERIDES INCREASED 17
465 BONE MARROW FAILURE 17
466 COGNITIVE DISORDER 17
467 CYTOGENETIC ABNORMALITY 17
468 DRUG RESISTANCE 17
469 GASTROINTESTINAL HAEMORRHAGE 17
470 LIMB INJURY 17
471 MENTAL DISORDER 17
472 MITRAL VALVE INCOMPETENCE 17
473 NEUTROPHIL COUNT DECREASED 17
474 PAPULE 17
475 SKIN HAEMORRHAGE 17
476 SKIN TIGHTNESS 17
477 ACNE CYSTIC 16
478 ARRHYTHMIA 16
479 ASPIRATION 16
480 CATARACT 16
481 CONVULSION 16
482 DERMATITIS CONTACT 16
483 DIPLOPIA 16
484 EMBEDDED DEVICE 16
485 FOREIGN BODY IN REPRODUCTIVE TRACT 16
486 HAEMATOCRIT DECREASED 16
487 HERPES ZOSTER 16
488 HYPERAESTHESIA 16
489 HYPERGLYCAEMIA 16
490 IMMUNODEFICIENCY 16
491 INJECTION SITE URTICARIA 16
492 INTERVERTEBRAL DISC PROTRUSION 16
493 INTESTINAL HAEMORRHAGE 16
494 LABORATORY TEST ABNORMAL 16
495 LACRIMATION INCREASED 16
496 LETHARGY 16
497 LIP SWELLING 16
498 PRODUCT DOSE OMISSION 16
499 PRODUCT PREPARATION ERROR 16
500 PROTEINURIA 16
501 RESTLESS LEGS SYNDROME 16
502 THERAPEUTIC RESPONSE SHORTENED 16
503 THROAT TIGHTNESS 16
504 VIRAL INFECTION 16
505 APHASIA 15
506 BACK DISORDER 15
507 CYST 15
508 DRUG TOLERANCE 15
509 GASTRITIS 15
510 GASTROINTESTINAL TOXICITY 15
511 HEAVY MENSTRUAL BLEEDING 15
512 IMPAIRED GASTRIC EMPTYING 15
513 PAIN IN JAW 15
514 PIGMENTATION DISORDER 15
515 RASH PAPULAR 15
516 SCRATCH 15
517 SEBORRHOEA 15
518 THERAPY PARTIAL RESPONDER 15
519 VITAMIN D DEFICIENCY 15
520 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 14
521 BACTERIAL INFECTION 14
522 DRUG EFFECT LESS THAN EXPECTED 14
523 EXPOSURE VIA SKIN CONTACT 14
524 HIP FRACTURE 14
525 IMPAIRED WORK ABILITY 14
526 INJECTION SITE RASH 14
527 INTERVERTEBRAL DISC DEGENERATION 14
528 LYMPHADENOPATHY 14
529 PELVIC PAIN 14
530 POOR QUALITY SLEEP 14
531 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 14
532 RENAL DISORDER 14
533 RENAL INJURY 14
534 RESPIRATORY TRACT INFECTION 14
535 SEASONAL ALLERGY 14
536 SINUS TACHYCARDIA 14
537 SKIN FISSURES 14
538 SKIN HYPERPIGMENTATION 14
539 TRICUSPID VALVE INCOMPETENCE 14
540 ACCIDENTAL OVERDOSE 13
541 ACUTE MYELOID LEUKAEMIA RECURRENT 13
542 ANKLE FRACTURE 13
543 BLOOD POTASSIUM DECREASED 13
544 CARDIOMYOPATHY 13
545 CHAPPED LIPS 13
546 CHROMATURIA 13
547 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 13
548 CLOSTRIDIUM DIFFICILE INFECTION 13
549 CYTOPENIA 13
550 DERMATITIS ACNEIFORM 13
551 DIVERTICULITIS 13
552 DRUG EFFECT DECREASED 13
553 DYSSTASIA 13
554 EMOTIONAL DISORDER 13
555 ENURESIS 13
556 FLATULENCE 13
557 HIDRADENITIS 13
558 HYPERSOMNIA 13
559 INFUSION SITE PAIN 13
560 INITIAL INSOMNIA 13
561 LEUKAEMIA 13
562 RED BLOOD CELL COUNT DECREASED 13
563 RESTLESSNESS 13
564 SKIN PLAQUE 13
565 SUBARACHNOID HAEMORRHAGE 13
566 TUBULOINTERSTITIAL NEPHRITIS 13
567 XEROSIS 13
568 BIPOLAR DISORDER 12
569 CANDIDA INFECTION 12
570 CARDIAC DISORDER 12
571 CENTRAL HYPOTHYROIDISM 12
572 COAGULOPATHY 12
573 CRYING 12
574 DEPRESSED LEVEL OF CONSCIOUSNESS 12
575 DEVICE RELATED INFECTION 12
576 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 12
577 DRUG TOLERANCE DECREASED 12
578 DYSPNOEA EXERTIONAL 12
579 EYELID OEDEMA 12
580 EYELID PTOSIS 12
581 FLUID OVERLOAD 12
582 GASTROENTERITIS VIRAL 12
583 HAIR TEXTURE ABNORMAL 12
584 HEAD INJURY 12
585 HEART RATE IRREGULAR 12
586 HEREDITARY ANGIOEDEMA 12
587 HYPERTRANSAMINASAEMIA 12
588 INCORRECT PRODUCT ADMINISTRATION DURATION 12
589 INJECTION SITE HAEMORRHAGE 12
590 MADAROSIS 12
591 MATERNAL EXPOSURE BEFORE PREGNANCY 12
592 MULTIPLE SCLEROSIS 12
593 NEPHROGENIC ANAEMIA 12
594 NEURALGIA 12
595 NIGHTMARE 12
596 OSTEONECROSIS OF JAW 12
597 PANCREATITIS ACUTE 12
598 PHOTOSENSITIVITY REACTION 12
599 PORPHYRIA ACUTE 12
600 PRODUCT ADMINISTRATION ERROR 12
601 PRODUCTIVE COUGH 12
602 SKIN PAPILLOMA 12
603 SPINAL FUSION SURGERY 12
604 SUNBURN 12
605 TOOTH DISORDER 12
606 WEIGHT FLUCTUATION 12
607 ABDOMINAL PAIN LOWER 11
608 ABNORMAL DREAMS 11
609 ACTIVITIES OF DAILY LIVING IMPAIRED 11
610 ADRENAL INSUFFICIENCY 11
611 ANGIOEDEMA 11
612 APPENDICITIS 11
613 BACTERIAL SEPSIS 11
614 BLOOD PRESSURE ABNORMAL 11
615 CENTRAL NERVOUS SYSTEM LESION 11
616 COMA 11
617 CONGENITAL ANOMALY 11
618 DYSARTHRIA 11
619 GENERAL SYMPTOM 11
620 HAEMATURIA 11
621 HALLUCINATION, VISUAL 11
622 HEPATIC FUNCTION ABNORMAL 11
623 HYPOGLYCAEMIA 11
624 INCONTINENCE 11
625 LOCALISED INFECTION 11
626 LYMPHOCYTE COUNT DECREASED 11
627 METABOLIC ACIDOSIS 11
628 MICTURITION URGENCY 11
629 MIDDLE INSOMNIA 11
630 MUSCLE TWITCHING 11
631 MYOCLONUS 11
632 OSTEONECROSIS 11
633 OVARIAN CYST 11
634 RASH MACULO-PAPULAR 11
635 ROSACEA 11
636 SCAB 11
637 SENSATION OF FOREIGN BODY 11
638 SKIN LACERATION 11
639 SKIN SWELLING 11
640 SWOLLEN TONGUE 11
641 TACHYPNOEA 11
642 TENDONITIS 11
643 THROAT IRRITATION 11
644 TRANSAMINASES INCREASED 11
645 TUMOUR LYSIS SYNDROME 11
646 UTERINE LEIOMYOMA 11
647 VITAMIN D DECREASED 11
648 BONE LOSS 10
649 BRAIN FOG 10
650 BRUXISM 10
651 CEREBRAL INFARCTION 10
652 CLOSTRIDIUM DIFFICILE COLITIS 10
653 DYSGEUSIA 10
654 DYSMENORRHOEA 10
655 DYSURIA 10
656 EJECTION FRACTION DECREASED 10
657 END STAGE RENAL DISEASE 10
658 ENDOMETRIOSIS 10
659 EYE INFECTION 10
660 FEELING DRUNK 10
661 GASTROENTERITIS 10
662 HAIR GROWTH ABNORMAL 10
663 HEAD DISCOMFORT 10
664 HUNGER 10
665 HYPOACUSIS 10
666 HYPOVOLAEMIA 10
667 INJECTION SITE MASS 10
668 INSURANCE ISSUE 10
669 LIMB DISCOMFORT 10
670 MAJOR DEPRESSION 10
671 MUSCLE DISORDER 10
672 MUSCULOSKELETAL CHEST PAIN 10
673 NERVOUS SYSTEM DISORDER 10
674 PROCEDURAL PAIN 10
675 PRODUCT COLOUR ISSUE 10
676 PRODUCT PREPARATION ISSUE 10
677 PRODUCT PRESCRIBING ERROR 10
678 PSYCHOLOGICAL TRAUMA 10
679 REBOUND EFFECT 10
680 SERONEGATIVE ARTHRITIS 10
681 SINUS DISORDER 10
682 SKIN MASS 10
683 SKIN REACTION 10
684 SMALL INTESTINAL OBSTRUCTION 10
685 SNORING 10
686 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 10
687 THIRST 10
688 TOOTHACHE 10
689 ANOSMIA 9
690 ATAXIA 9
691 BACTERAEMIA 9
692 BRAIN OEDEMA 9
693 CHLOASMA 9
694 CONGENITAL KNEE DISLOCATION 9
695 CONGENITAL MUSCULOSKELETAL ANOMALY 9
696 COORDINATION ABNORMAL 9
697 DEVICE MALFUNCTION 9
698 DRUG DEPENDENCE 9
699 DRUG ERUPTION 9
700 ENDOCARDITIS 9
701 EXTRA DOSE ADMINISTERED 9
702 EYE DISCHARGE 9
703 EYE HAEMORRHAGE 9
704 GENERALISED TONIC-CLONIC SEIZURE 9
705 GUILLAIN-BARRE SYNDROME 9
706 HAEMOPTYSIS 9
707 HAIR COLOUR CHANGES 9
708 HYPERBILIRUBINAEMIA 9
709 HYPERKALAEMIA 9
710 HYPERLIPIDAEMIA 9
711 HYPERTONIC BLADDER 9
712 HYPERTRIGLYCERIDAEMIA 9
713 HYPOALBUMINAEMIA 9
714 HYPOPHAGIA 9
715 IIIRD NERVE PARALYSIS 9
716 ILEUS 9
717 INCORRECT DRUG ADMINISTRATION DURATION 9
718 LARGE GRANULAR LYMPHOCYTOSIS 9
719 LYMPHOCYTOSIS 9
720 MACULOPATHY 9
721 MASS 9
722 MENTAL IMPAIRMENT 9
723 MOOD ALTERED 9
724 MULTIPLE SCLEROSIS RELAPSE 9
725 NERVOUSNESS 9
726 PARAESTHESIA ORAL 9
727 PERIORBITAL SWELLING 9
728 PERIPHERAL COLDNESS 9
729 PHARYNGITIS 9
730 POLYARTHRITIS 9
731 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 9
732 PRODUCT DISPENSING ERROR 9
733 PRODUCT FORMULATION ISSUE 9
734 PRODUCT ODOUR ABNORMAL 9
735 RHABDOMYOLYSIS 9
736 RHINITIS ALLERGIC 9
737 SECRETION DISCHARGE 9
738 SHOCK 9
739 SINUS CONGESTION 9
740 SKIN EROSION 9
741 SKIN WEEPING 9
742 SOMNAMBULISM 9
743 STEM CELL TRANSPLANT 9
744 THROMBOCYTOSIS 9
745 THROMBOPHLEBITIS SUPERFICIAL 9
746 TOOTH EXTRACTION 9
747 TOOTH LOSS 9
748 URINARY INCONTINENCE 9
749 VAGINAL INFECTION 9
750 VENTRICULAR TACHYCARDIA 9
751 WITHDRAWAL SYNDROME 9
752 ABNORMAL UTERINE BLEEDING 8
753 AFFECTIVE DISORDER 8
754 ANAL FISSURE 8
755 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 8
756 APLASTIC ANAEMIA 8
757 APNOEA 8
758 APPLICATION SITE REACTION 8
759 APPLICATION SITE VESICLES 8
760 ATELECTASIS 8
761 AXONAL NEUROPATHY 8
762 BASAL CELL CARCINOMA 8
763 BLINDNESS 8
764 BREAST CANCER 8
765 BREAST MASS 8
766 CARDIAC MURMUR 8
767 CARDIO-RESPIRATORY ARREST 8
768 CARDIOGENIC SHOCK 8
769 CARDIOTOXICITY 8
770 COMPLICATION ASSOCIATED WITH DEVICE 8
771 CYSTITIS 8
772 DENTAL CARIES 8
773 DERMATITIS EXFOLIATIVE 8
774 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 8
775 FEAR 8
776 FRACTURE 8
777 GASTRIC ULCER 8
778 GASTROINTESTINAL PAIN 8
779 GLUCOSE TOLERANCE IMPAIRED 8
780 HEPATIC FAILURE 8
781 HYPERKERATOSIS 8
782 INJECTION SITE IRRITATION 8
783 LUNG INFILTRATION 8
784 MALNUTRITION 8
785 MELANOCYTIC NAEVUS 8
786 MENSTRUATION IRREGULAR 8
787 MOOD SWINGS 8
788 MOUTH ULCERATION 8
789 MUSCLE SPASTICITY 8
790 MUSCLE TIGHTNESS 8
791 MUSCULOSKELETAL DISORDER 8
792 MYELODYSPLASTIC SYNDROME WITH EXCESS BLASTS 8
793 NEOPLASM 8
794 NEUROLOGICAL DECOMPENSATION 8
795 NOCTURIA 8
796 PALLOR 8
797 PLATELET COUNT INCREASED 8
798 POLYARTERITIS NODOSA 8
799 POST-TRAUMATIC STRESS DISORDER 8
800 POTENTIATING DRUG INTERACTION 8
801 PSEUDOMONAS INFECTION 8
802 PSYCHOTIC DISORDER 8
803 PULMONARY TUBERCULOSIS 8
804 RESPIRATORY TRACT CONGESTION 8
805 RETINAL HAEMORRHAGE 8
806 RIB FRACTURE 8
807 SCROTAL ULCER 8
808 SEDATION 8
809 SENSITIVE SKIN 8
810 SEROUS RETINAL DETACHMENT 8
811 SIMPLE PARTIAL SEIZURES 8
812 SKIN NECROSIS 8
813 SPINAL OSTEOARTHRITIS 8
814 STEVENS-JOHNSON SYNDROME 8
815 TUBERCULOSIS 8
816 UPPER-AIRWAY COUGH SYNDROME 8
817 URINARY RETENTION 8
818 VISUAL ACUITY REDUCED 8
819 VITH NERVE PARALYSIS 8
820 WRONG TECHNIQUE IN DRUG USAGE PROCESS 8
821 ABNORMAL BEHAVIOUR 7
822 AMENORRHOEA 7
823 ANAPHYLACTIC SHOCK 7
824 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 7
825 APATHY 7
826 APPLICATION SITE PAPULES 7
827 ARTHROPOD BITE 7
828 ASCITES 7
829 BILIARY DYSKINESIA 7
830 BLOOD GLUCOSE DECREASED 7
831 BLOOD LACTATE DEHYDROGENASE INCREASED 7
832 BLOOD SODIUM DECREASED 7
833 BLOOD UREA INCREASED 7
834 CHOLECYSTITIS 7
835 CONCUSSION 7
836 DEAFNESS 7
837 DERMATITIS ALLERGIC 7
838 EATING DISORDER 7
839 EMBOLISM 7
840 ERECTILE DYSFUNCTION 7
841 EYE INJURY 7
842 FLANK PAIN 7
843 GASTRIC DISORDER 7
844 GINGIVITIS 7
845 GOUT 7
846 HAEMATOMA 7
847 HAEMATOTOXICITY 7
848 HAIR DISORDER 7
849 HEART RATE DECREASED 7
850 HYPOTONIA 7
851 HYSTERECTOMY 7
852 INFUSION SITE ERYTHEMA 7
853 INFUSION SITE EXTRAVASATION 7
854 IRON DEFICIENCY ANAEMIA 7
855 ISCHAEMIC HEPATITIS 7
856 ISCHAEMIC STROKE 7
857 JAUNDICE 7
858 JOINT DESTRUCTION 7
859 KERATITIS 7
860 KIDNEY FIBROSIS 7
861 LIGAMENT SPRAIN 7
862 LIQUID PRODUCT PHYSICAL ISSUE 7
863 LONG QT SYNDROME 7
864 MENORRHAGIA 7
865 MUSCULOSKELETAL DISCOMFORT 7
866 MYOPERICARDITIS 7
867 NECROTISING FASCIITIS 7
868 NODULE 7
869 OBSESSIVE-COMPULSIVE DISORDER 7
870 ORAL DISORDER 7
871 OSTEOMYELITIS 7
872 OVERWEIGHT 7
873 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 7
874 PNEUMONITIS 7
875 PNEUMOTHORAX 7
876 POST PROCEDURAL INFECTION 7
877 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 7
878 PRODUCT DISTRIBUTION ISSUE 7
879 PRODUCT LEAKAGE 7
880 PULMONARY ALVEOLAR HAEMORRHAGE 7
881 PULMONARY CONGESTION 7
882 PULMONARY HYPERTENSION 7
883 QUALITY OF LIFE DECREASED 7
884 RAYNAUD^S PHENOMENON 7
885 RIGHT VENTRICULAR SYSTOLIC PRESSURE INCREASED 7
886 ROTATOR CUFF SYNDROME 7
887 SARS-COV-2 TEST POSITIVE 7
888 SKIN TEXTURE ABNORMAL 7
889 SKIN ULCER 7
890 SPINAL FRACTURE 7
891 STRIDOR 7
892 TEMPOROMANDIBULAR JOINT SYNDROME 7
893 TERMINAL INSOMNIA 7
894 THERMAL BURN 7
895 TOXIC ENCEPHALOPATHY 7
896 ULCER 7
897 VENTRICULAR FIBRILLATION 7
898 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 6
899 ACUTE HEPATIC FAILURE 6
900 AGEUSIA 6
901 ANAL FISTULA 6
902 ANOREXIA 6
903 APHTHOUS STOMATITIS 6
904 APPLICATION SITE BURN 6
905 APPLICATION SITE INFLAMMATION 6
906 ASPERGILLUS INFECTION 6
907 BICYTOPENIA 6
908 BILIARY COLIC 6
909 BODY HEIGHT DECREASED 6
910 BONE DISORDER 6
911 BRONCHOPULMONARY ASPERGILLOSIS 6
912 CARDIAC TAMPONADE 6
913 CARDIOMEGALY 6
914 CARDIOVASCULAR DISORDER 6
915 CEREBRAL ISCHAEMIA 6
916 CHEMICAL BURN OF SKIN 6
917 CHLOROMA 6
918 CHROMOSOMAL DELETION 6
919 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 6
920 COMPLETED SUICIDE 6
921 DARK CIRCLES UNDER EYES 6
922 DEVICE FAILURE 6
923 DEVICE USE ISSUE 6
924 DIVERTICULUM INTESTINAL 6
925 DRUG ADMINISTERED AT INAPPROPRIATE SITE 6
926 DRUG EFFECT INCOMPLETE 6
927 DRUG WITHDRAWAL SYNDROME 6
928 DYSKINESIA 6
929 EAR DISCOMFORT 6
930 EXERCISE TOLERANCE DECREASED 6
931 FACE OEDEMA 6
932 FEEDING DISORDER 6
933 FEELING JITTERY 6
934 FEMUR FRACTURE 6
935 FOOD ALLERGY 6
936 FORMICATION 6
937 FURUNCLE 6
938 GINGIVAL BLEEDING 6
939 GLOMERULAR FILTRATION RATE DECREASED 6
940 HEPATOMEGALY 6
941 HORMONE LEVEL ABNORMAL 6
942 HYPOCALCAEMIA 6
943 HYPOMAGNESAEMIA 6
944 INCREASED TENDENCY TO BRUISE 6
945 INFUSION SITE BRUISING 6
946 INFUSION SITE HAEMORRHAGE 6
947 INTRAOCULAR PRESSURE INCREASED 6
948 LACERATION 6
949 LIBIDO DECREASED 6
950 LIVER FUNCTION TEST ABNORMAL 6
951 MEAN CELL VOLUME INCREASED 6
952 MENTAL STATUS CHANGES 6
953 MOVEMENT DISORDER 6
954 MULTI-ORGAN DISORDER 6
955 MULTIPLE FRACTURES 6
956 MYASTHENIA GRAVIS 6
957 MYDRIASIS 6
958 NEOPLASM MALIGNANT 6
959 NEURODERMATITIS 6
960 OBSTRUCTIVE SLEEP APNOEA SYNDROME 6
961 ORTHOSTATIC HYPOTENSION 6
962 PERONEAL NERVE PALSY 6
963 PHARMACEUTICAL PRODUCT COMPLAINT 6
964 PNEUMOCYSTIS JIROVECII PNEUMONIA 6
965 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 6
966 PREMATURE DELIVERY 6
967 PROCTALGIA 6
968 PROCTITIS 6
969 PRODUCT CONTAINER ISSUE 6
970 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 6
971 PRODUCT PACKAGING QUANTITY ISSUE 6
972 PRODUCT PHYSICAL ISSUE 6
973 PRODUCT RESIDUE PRESENT 6
974 PRODUCT USE COMPLAINT 6
975 PROTEIN TOTAL DECREASED 6
976 PRURITUS GENITAL 6
977 PULMONARY MASS 6
978 PUSTULE 6
979 PYELONEPHRITIS 6
980 REBOUND ATOPIC DERMATITIS 6
981 RESPIRATORY ARREST 6
982 RETCHING 6
983 RHINITIS 6
984 SENSORY DISTURBANCE 6
985 SERUM FERRITIN ABNORMAL 6
986 SKIN DISCOMFORT 6
987 SPONDYLITIS 6
988 TEMPERATURE INTOLERANCE 6
989 TINEA VERSICOLOUR 6
990 TOOTH ABSCESS 6
991 UROSEPSIS 6
992 VASCULITIS 6
993 VENOOCCLUSIVE LIVER DISEASE 6
994 VULVOVAGINAL PAIN 6
995 WERNICKE^S ENCEPHALOPATHY 6
996 ABASIA 5
997 ABORTION INDUCED 5
998 ACNE PUSTULAR 5
999 ACQUIRED GENE MUTATION 5